Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Obstructive Lung Diseases

  Free Subscription


Articles published in J Investig Allergol Clin Immunol

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    March 2026
  1. IZAGUIRRE-FLORES H, Arismendi E, Martin-Ruiz de la Rosa E, Roman-Bernal B, et al
    Real-World Experience With Dupilumab in Severe Asthma: The Spanish Multicenter Study DUPImpact.
    J Investig Allergol Clin Immunol. 2026 Mar 30:0. doi: 10.18176/jiaci.1156.
    PubMed     Abstract available


  2. CREMADES-JIMENO L, Lopez-Ramos M, Baos S, Fernandez-Santamaria R, et al
    Development of a Panel of Molecular Biomarkers of Asthma: Analysis of Differential Expression and Stability Over Time.
    J Investig Allergol Clin Immunol. 2026 Mar 26:0. doi: 10.18176/jiaci.1168.
    PubMed     Abstract available


    January 2026
  3. LOPEZ-GONZALEZ P, Vazquez de la Torre M, Garcia-Moguel I, Juarez Rodriguez C, et al
    Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps: Simultaneous Response to Dupilumab.
    J Investig Allergol Clin Immunol. 2026 Jan 13:0. doi: 10.18176/jiaci.1150.
    PubMed    


    December 2025
  4. DEVILLIER P, Demoly P, Bergmann JF, Delaisi B, et al
    Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI Study.
    J Investig Allergol Clin Immunol. 2025 Dec 11:0. doi: 10.18176/jiaci.1142.
    PubMed     Abstract available


  5. SOLER-SEGOVIA D, Romero-Mesones C, Espejo D, Pilia F, et al
    Inflammatory and Immune Effects of Pollution: Comparison Between Patients With Asthma and Healthy Individuals.
    J Investig Allergol Clin Immunol. 2025 Dec 4:0. doi: 10.18176/jiaci.1094.
    PubMed     Abstract available


  6. MORENO-CONDE A, Moreno-Conde J, Guardia-Martinez P, Vilches-Arenas A, et al
    Prevalence, Treatment Trajectories, and Environmental Exacerbation Factors in Asthma: A Regional Study in Andalusia.
    J Investig Allergol Clin Immunol. 2025 Dec 3:0. doi: 10.18176/jiaci.1096.
    PubMed     Abstract available


    November 2025
  7. GALVAN CA, Duran R, Quirce S
    A Critical Review of Occupational Asthma in the 21st Century Work Environment.
    J Investig Allergol Clin Immunol. 2025 Nov 5:0. doi: 10.18176/jiaci.1123.
    PubMed     Abstract available


    October 2025
  8. ESTRAVIS M, Carreiras-Quintas D, Trivino JC, Perez-Pazos J, et al
    Identification of Dual Super-Response in Patients With Asthma and CRSwNP Treated With Mepolizumab.
    J Investig Allergol Clin Immunol. 2025 Oct 24:0. doi: 10.18176/jiaci.1102.
    PubMed     Abstract available


    July 2025
  9. SALDANA-PEREZ LE, Serrano Pariente J, Cisneros Serrano C, Plaza V, et al
    Dynamic Hyperinflation in Patients With Moderate-Severe Asthma: Relationship With Clinical Control and Small Airway Dysfunction.
    J Investig Allergol Clin Immunol. 2025 Jul 30:0. doi: 10.18176/jiaci.1088.
    PubMed     Abstract available


    April 2025
  10. CALZADA D, Bartra J, Serrano CD, Riggioni S, et al
    Differences in Molecular Sensitization Profiles Between Spanish and Latin American Mite-Allergic Patients.
    J Investig Allergol Clin Immunol. 2025;35:114-121.
    PubMed     Abstract available


    March 2025
  11. GARCIA-RIO F
    The Evolving Role of Lung Function Interpretation: Clinical Implications of the new ERS/ATS Standards in Asthma Care.
    J Investig Allergol Clin Immunol. 2025 Mar 14:0. doi: 10.18176/jiaci.1084.
    PubMed     Abstract available


  12. BANTULA M, Garcia A, Picado C, Arismendi E, et al
    Obese Asthma Syndrome: Multiple Inflammatory Patterns and A Key Solution.
    J Investig Allergol Clin Immunol. 2025 Mar 5:0. doi: 10.18176/jiaci.1071.
    PubMed    


    January 2025
  13. SOUSA-PINTO B, Savoure M, Vieira RJ, Amaral R, et al
    Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.
    J Investig Allergol Clin Immunol. 2025 Jan 23:0. doi: 10.18176/jiaci.1047.
    PubMed     Abstract available


    November 2024
  14. OJANGUREN I, Quirce S, Bobolea I, Perez de Llano L, et al
    Phenotyping Asthma Exacerbations: One Step Further in the Management of Severe Asthma.
    J Investig Allergol Clin Immunol. 2024 Nov 28:0. doi: 10.18176/jiaci.1043.
    PubMed     Abstract available


  15. MASCARO-HEREZA B, Loli-Ausejo D, Valero A, Arismendi E, et al
    Effectiveness of Biologics in Patients With Severe Asthma and Psychiatric Comorbidities.
    J Investig Allergol Clin Immunol. 2024 Nov 27:0. doi: 10.18176/jiaci.1034.
    PubMed    


  16. RIAL MJ, Betancor D, Canas JA, Olaguibel JM, et al
    Stability of Asthma Phenotypes in the Spanish Cohort of the MEGA Project.
    J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1026.
    PubMed    


  17. MIRALLES-LOPEZ JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, et al
    Tezepelumab in Patients With Severe Asthma: Response at 3 Months.
    J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1041.
    PubMed    


  18. OZDEMIR O
    Occupational Asthma and Rhinoconjunctivitis due to Soybean in a Bakery Worker.
    J Investig Allergol Clin Immunol. 2024 Nov 13:0. doi: 10.18176/jiaci.1035.
    PubMed    


  19. LOZANO-ESPINOSA M, Rodriguez-Otero N, Antolin-Amerigo D, Gordo Vidal F, et al
    Characteristics of Asthma Patients Admitted to the Intensive Care Unit of a Tertiary University Hospital in Madrid, Spain: A 5-Year Experience.
    J Investig Allergol Clin Immunol. 2024 Nov 12:0. doi: 10.18176/jiaci.1021.
    PubMed    


    October 2024
  20. POLA-BIBIAN B, Dominguez-Ortega J, Vila-Nadal G, Entrala A, et al
    Asthma Exacerbations in a Tertiary Hospital: Clinical Features, Triggers, and Risk Factors for Hospitalization.
    J Investig Allergol Clin Immunol. 2024;27:238-245.
    PubMed     Abstract available


  21. PLAZA V, Eguiluz I, Garin N, Martinez Moragon E, et al
    EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma.
    J Investig Allergol Clin Immunol. 2024;34:336-338.
    PubMed    


    July 2024
  22. VENEGAS GARRIDO C, Nair P, Davila I, Perez de Llano L, et al
    Role of Thymic Stromal Lymphopoietin in the Pathophysiology of Asthma and Clinical and Biological Effects of Blockade With Tezepelumab.
    J Investig Allergol Clin Immunol. 2024 Jul 26:0. doi: 10.18176/jiaci.1012.
    PubMed     Abstract available


    June 2024
  23. BETANCOR D, Otal M, Olaguibel JM, Rodrigo-Munoz JM, et al
    Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort.
    J Investig Allergol Clin Immunol. 2024;34:192-195.
    PubMed    


  24. ZAKZUK J, Donado K, Mondol E, Marrugo V, et al
    IgE-Mediated Sensitization to Blo t 21 and Blo t 5 Is Associated With Asthma in the Tropics: A Case-Control Study.
    J Investig Allergol Clin Immunol. 2024;34:157-166.
    PubMed     Abstract available


    May 2024
  25. SOUSA-PINTO B, Fonseca JA, Bousquet J
    Contribution of MASK-air(R) as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma.
    J Investig Allergol Clin Immunol. 2024 May 14:0. doi: 10.18176/jiaci.0994.
    PubMed     Abstract available


  26. TOMAS-PEREZ M, Trisan Alonso A, Montoro-Ferrer A, Dominguez-Ortega J, et al
    Concomitant Efficacy of Dupilumab in Treating Eosinophilic Esophagitis and Type 2 Asthma.
    J Investig Allergol Clin Immunol. 2024 May 9:0. doi: 10.18176/jiaci.1011.
    PubMed    


    April 2024
  27. DE LAS VECILLAS L, Quirce S
    The Multiple Trajectories of the Allergic March.
    J Investig Allergol Clin Immunol. 2024;34:75-84.
    PubMed     Abstract available


    February 2024
  28. SOUSA-PINTO B, Palamarchuk Y, Leemann L, Jankin S, et al
    From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe).
    J Investig Allergol Clin Immunol. 2024;34:12-19.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum